Search
for
Sort by
Research 151–180 of 1000+
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Kawasaki disease: an update
- CUTANEOUS T-CELL LYMPHOMA
- Clinical Development of Topoisomerase-Interactive Drugs
- Benign Cutaneous Eruptions After Transplantation
- Risk factors for prostate cancer: a case-control study investigating selected key exposures and their interactions with predisposition genes
- Liposomal systems as drug delivery vehicles for dermal and transdermal applications
- Acne-associated syndromes: models for better understanding of acne pathogenesis
- Tinea Capitis: An Overview with Emphasis on Management
- Trichodysplasia of immunosuppression treated with oral valganciclovir
- Cutaneous Markers of Disorders Affecting Adult Horses
- Conceptual Basis for Use of Chemotherapeutic Agents and Their Pharmacology
- Drug Information Analysis Service
- Biological Profile of Cortexolone 17a-Propionate (CB-03-01), a New Topical and Peripherally Selective Androgen Antagonist
- Clinical Trials and Hair Loss
- The Endoscopic Brow Lift
- The eosinophilia-myalgia syndrome
- Management of Toxicities of Targeted Therapies
- Dermatologic therapy: December 1987 to December 1988
- Psychotropic Treatment of Psychodermatologic Disorders
- A systematic review of pulse steroid therapy for alopecia areata
- A 36-Year-Old Woman With an Unexpected Cause of Hypokalemia
- Mitoxantrone
- Vogt-Koyanagi-Harada Disease in which Poliosis and Alopecia Occurred after a Long Period of Time.
- Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients
- Refractory/relapse thrombocytopenia in a patient with Evans' syndrome successfully treated with zanubrutinib
- Successful management of Netherton syndrome using IVIG and dupilumab: A case report
- Weekly azathioprine pulse versus betamethasone oral mini-pulse in the treatment of moderate-to-severe alopecia areata
- Aggressive treatment in paediatric or young patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with future development of type III polyglandular autoimmune syndrome
- The use of oral recombinant feline interferon omega in two cats with type II diabetes mellitus and concurrent feline chronic gingivostomatitis syndrome